evaluate the pharmaceuticals company wegovy on glp-1 drugs for diabetes What Are Side Effects of and Ozempic? Wegovy for Weight Loss: Benefits
Description
Importantly, GLP-1 receptor agonists are not recommended for patients with severe gastroparesis, as they may further delay gastric emptying and worsen symptoms
The study design incorporated two reference groups (diabetes and overweight/obese), to reduce the influence of potential confounding variables
The consistent reductions in BMI and body weight across various studies highlight the potential of GLP-1RAs in managing PCOS-related conditions, even in populations where metformin has traditionally been the first-line therapy
[DOI] [PubMed] [Google Scholar] 49.He Y.-L., Sadler B.M., Sabo R., Balez S., Wang Y., Campestrini J., Laurent A., Ligueros-Saylan M., Howard D
The selected studies were published between 2015 and 2019
